CHMP Opinions June 2026
The CHMP (Committee for Medicinal Products for Human Use) is the EMA committee whose monthly opinions decide whether new medicines are recommended for approval in the EU. A positive opinion is normally followed by European Commission authorisation within ~67 days. Dates below come from official CHMP meeting agendas and highlights.
- CHMP opinion ACAD ACADIA Pharmaceuticals Inc. CHMP positive opinion: ACADIA Pharmaceuticals Inc. — Daybu 2026-06-25
- CHMP opinion BAVA.CO Bavarian Nordic A/S CHMP positive opinion: Bavarian Nordic A/S — Imvanex 2026-06-25
- CHMP opinion INCY Incyte Corporation CHMP positive opinion: Incyte Corporation — Opzelura 2026-06-25
- CHMP opinion NOVN.SW Novartis AG CHMP positive opinion: Novartis AG — Leqvio 2026-06-25
- CHMP opinion SNY Sanofi CHMP positive opinion: Sanofi — MenQuadfi 2026-06-25
- CHMP opinion VLA.PA Valneva SE CHMP positive opinion: Valneva SE — Ixchiq 2026-06-25
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.